Top

Published in:

01-10-2016 | Review

The quest to make fully functional human pancreatic beta cells from embryonic stem cells: climbing a mountain in the clouds

Author: James D. Johnson

Published in: Diabetologia | Issue 10/2016

Abstract

The production of fully functional insulin-secreting cells to treat diabetes is a major goal of regenerative medicine. In this article, I review progress towards this goal over the last 15 years from the perspective of a beta cell biologist. I describe the current state-of-the-art, and speculate on the general approaches that will be required to identify and achieve our ultimate goal of producing functional beta cells. The need for deeper phenotyping of heterogeneous cultures of stem cell derived islet-like cells in parallel with a better understanding of the heterogeneity of the target cell type(s) is emphasised. This deep phenotyping should include high-throughput single-cell analysis, as well as comprehensive ’omics technologies to provide unbiased characterisation of cell products and human beta cells. There are justified calls for more detailed and well-powered studies of primary human pancreatic beta cell physiology, and I propose online databases of standardised human beta cell responses to physiological stimuli, including both functional and metabolomic/proteomic/transcriptomic profiles. With a concerted, community-wide effort, including both basic and applied scientists, beta cell replacement will become a clinical reality for patients with diabetes.

Available only for authorised users

Ryan EA, Paty BW, Senior PA et al (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54:2060–2069CrossRefPubMed

Thompson DM, Meloche M, Ao Z et al (2011) Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation 91:373–378CrossRefPubMed

Bruin JE, Rezania A, Kieffer TJ (2015) Replacing and safeguarding pancreatic β cells for diabetes. Sci Transl Med 7:316ps323CrossRef

Misler S, Barnett DW, Gillis KD, Pressel DM (1992) Electrophysiology of stimulus-secretion coupling in human β-cells. Diabetes 41:1221–1228CrossRefPubMed

Keenan HA, Sun JK, Levine J et al (2010) Residual insulin production and pancreatic β-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 59:2846–2853CrossRefPubMedPubMedCentral

Smukler SR, Arntfield ME, Razavi R et al (2011) The adult mouse and human pancreas contain rare multipotent stem cells that express insulin. Cell Stem Cell 8:281–293CrossRefPubMed

Chera S, Baronnier D, Ghila L et al (2014) Diabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers. Nature 514:503–507CrossRefPubMedPubMedCentral

Thorel F, Nepote V, Avril I et al (2010) Conversion of adult pancreatic α-cells to β-cells after extreme β-cell loss. Nature 464:1149–1154CrossRefPubMedPubMedCentral

Kushner JA (2013) The role of aging upon β cell turnover. J Clin Invest 123:990–995CrossRefPubMedPubMedCentral

10.

Kushner JA, MacDonald PE, Atkinson MA (2014) Stem cells to insulin secreting cells: two steps forward and now a time to pause? Cell Stem Cell 15:535–536CrossRefPubMed

11.

Pagliuca FW, Melton DA (2013) How to make a functional β-cell. Development 140:2472–2483CrossRefPubMedPubMedCentral

12.

Bartlett ST, Markmann JF, Johnson P et al (2016) Report from IPITA-TTS opinion leaders meeting on the future of β-cell replacement. Transplantation 100(Suppl 2):S1–S44CrossRefPubMedPubMedCentral

13.

Dominguez-Bendala J, Lanzoni G, Klein D, Alvarez-Cubela S, Pastori RL (2016) The human endocrine pancreas: new insights on replacement and regeneration. Trends Endocrinol Metab 27:153–162CrossRefPubMed

14.

Quiskamp N, Bruin JE, Kieffer TJ (2015) Differentiation of human pluripotent stem cells into β-cells: potential and challenges. Best Pract Res Clin Endocrinol Metab 29:833–847CrossRefPubMed

15.

Hanley N (2014) Closing in on pancreatic beta cells. Nat Biotechnol 32:1100–1102CrossRefPubMed

16.

Leon-Quinto T, Jones J, Skoudy A, Burcin M, Soria B (2004) In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. Diabetologia 47:1442–1451CrossRefPubMed

17.

Soria B (2001) In-vitro differentiation of pancreatic β-cells. Differentiation 68:205–219CrossRefPubMed

18.

Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:1389–1394CrossRefPubMed

19.

Shiroi A, Yoshikawa M, Yokota H et al (2002) Identification of insulin-producing cells derived from embryonic stem cells by zinc-chelating dithizone. Stem Cells 20:284–292CrossRefPubMed

20.

Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA, Martin F (2000) Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49:157–162CrossRefPubMed

21.

Hori Y, Rulifson IC, Tsai BC, Heit JJ, Cahoy JD, Kim SK (2002) Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A 99:16105–16110CrossRefPubMedPubMedCentral

22.

Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M (2001) Insulin production by human embryonic stem cells. Diabetes 50:1691–1697CrossRefPubMed

23.

Treutelaar MK, Skidmore JM, Dias-Leme CL et al (2003) Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet. Diabetes 52:2503–2512CrossRefPubMed

24.

Sipione S, Eshpeter A, Lyon JG, Korbutt GS, Bleackley RC (2004) Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia 47:499–508CrossRefPubMed

25.

Mehran AE, Templeman NM, Brigidi GS et al (2012) Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab 16:723–737CrossRefPubMed

26.

McKiernan E, Barron NW, O’Sullivan F, Barham P, Clynes M, O’Driscoll L (2007) Detecting de novo insulin synthesis in embryonic stem cell-derived populations. Exp Cell Res 313:1405–1414CrossRef

27.

Hansson M, Tonning A, Frandsen U et al (2004) Artifactual insulin release from differentiated embryonic stem cells. Diabetes 53:2603–2609CrossRefPubMed

28.

Micallef SJ, Janes ME, Knezevic K, Davis RP, Elefanty AG, Stanley EG (2005) Retinoic acid induces Pdx1-positive endoderm in differentiating mouse embryonic stem cells. Diabetes 54:301–305CrossRefPubMed

29.

D’Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE (2005) Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23:1534–1541CrossRefPubMed

30.

D’Amour KA, Bang AG, Eliazer S et al (2006) Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 24:1392–1401CrossRefPubMed

31.

Hrvatin S, O’Donnell CW, Deng F et al (2014) Differentiated human stem cells resemble fetal, not adult, β cells. Proc Natl Acad Sci U S A 111:3038–3043CrossRefPubMedPubMedCentral

32.

Basford CL, Prentice KJ, Hardy AB et al (2012) The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic beta cells. Diabetologia 55:358–371CrossRefPubMed

33.

Takeuchi H, Nakatsuji N, Suemori H (2014) Endodermal differentiation of human pluripotent stem cells to insulin-producing cells in 3D culture. Sci Rep 4:4488PubMedPubMedCentral

34.

Nostro MC, Sarangi F, Ogawa S et al (2011) Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 138:861–871CrossRefPubMedPubMedCentral

35.

Bruin JE, Erener S, Vela J et al (2014) Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cells. Stem Cell Res 12:194–208CrossRefPubMed

36.

Kroon E, Martinson LA, Kadoya K et al (2008) Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26:443–452CrossRefPubMed

37.

Motte E, Szepessy E, Suenens K et al (2014) Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts. Am J Physiol Endocrinol Metab 307:E838–E846CrossRefPubMed

38.

Bruin JE, Rezania A, Xu J et al (2013) Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice. Diabetologia 56:1987–1998CrossRefPubMed

39.

Bruin JE, Asadi A, Fox JK, Erener S, Rezania A, Kieffer TJ (2015) Accelerated maturation of human stem cell-derived pancreatic progenitor cells into insulin-secreting cells in immunodeficient rats relative to mice. Stem Cell Rep 5:1081–1096CrossRef

40.

Rezania A, Bruin JE, Arora P et al (2014) Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol 32:1121–1133CrossRefPubMed

41.

Wills QF, Boothe T, Asadi A et al (2016) Statistical approaches and software for clustering islet cell functional heterogeneity. Islets 8:48–56CrossRefPubMedPubMedCentral

42.

Pagliuca FW, Millman JR, Gurtler M et al (2014) Generation of functional human pancreatic β cells in vitro. Cell 159:428–439CrossRefPubMedPubMedCentral

43.

Vegas AJ, Veiseh O, Gürtler M et al (2016) Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med 22:306–311CrossRefPubMedPubMedCentral

44.

Russ HA, Parent AV, Ringler JJ et al (2015) Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro. EMBO J 34:1759–1772CrossRefPubMedPubMedCentral

45.

Szabat M, Modi H, Ramracheya R et al (2015) High-content screening identifies a role for Na⁺ channels in insulin production. R Soc Open Sci 2:150306CrossRefPubMedPubMedCentral

46.

Scharfmann R, Pechberty S, Hazhouz Y et al (2014) Development of a conditionally immortalized human pancreatic β cell line. J Clin Invest 124:2087–2098CrossRefPubMedPubMedCentral

47.

Korsgren E, Korsgren O (2016) Glucose effectiveness: the mouse trap in the development of novel β-cell replacement therapies. Transplantation 100:111–115CrossRefPubMed

48.

Rutter GA, Pullen TJ, Hodson DJ, Martinez-Sanchez A (2015) Pancreatic β-cell identity, glucose sensing and the control of insulin secretion. Biochem J 466:203–218CrossRefPubMed

49.

Lyon J, Manning Fox JE, Spigelman AF et al (2016) Research-focused isolation of human islets from donors with and without diabetes at the Alberta Diabetes Institute IsletCore. Endocrinology 157:560–569CrossRefPubMed

50.

Street CN, Lakey JR, Shapiro AM et al (2004) Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes 53:3107–3114CrossRefPubMed

51.

van de Bunt M, Manning Fox JE, Dai X et al (2015) Transcript expression data from human islets links regulatory signals from genome-wide association studies for type 2 diabetes and glycemic traits to their downstream effectors. PLoS Genet 11:e1005694CrossRefPubMedPubMedCentral

52.

Yang YH, Szabat M, Bragagnini C et al (2011) Paracrine signalling loops in adult human and mouse pancreatic islets: netrins modulate beta cell apoptosis signalling via dependence receptors. Diabetologia 54:828–842CrossRefPubMed

53.

Yang YH, Manning Fox JE, Zhang KL, MacDonald PE, Johnson JD (2013) Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion. Proc Natl Acad Sci U S A 110:16480–16485CrossRefPubMedPubMedCentral

54.

Yang YH, Wills QF, Johnson JD (2015) A live-cell, high-content imaging survey of 206 endogenous factors across five stress conditions reveals context-dependent survival effects in mouse primary beta cells. Diabetologia 58:1239–1249CrossRefPubMedPubMedCentral

55.

Vomund AN, Zinselmeyer BH, Hughes J et al (2015) Beta cells transfer vesicles containing insulin to phagocytes for presentation to T cells. Proc Natl Acad Sci U S A 112:E5496–E5502CrossRefPubMedPubMedCentral

56.

Halban PA, Wollheim CB, Blondel B, Meda P, Niesor EN, Mintz DH (1982) The possible importance of contact between pancreatic islet cells for the control of insulin release. Endocrinology 111:86–94CrossRefPubMed

57.

Benninger RK, Head WS, Zhang M, Satin LS, Piston DW (2011) Gap junctions and other mechanisms of cell-cell communication regulate basal insulin secretion in the pancreatic islet. J Physiol 589:5453–5466CrossRefPubMedPubMedCentral

58.

Nourmohammadzadeh M, Xing Y, Lee JW et al (2016) A microfluidic array for real-time live-cell imaging of human and rodent pancreatic islets. Lab Chip 16:1466–1472CrossRefPubMed

59.

Pedraza E, Karajic A, Raoux M et al (2015) Guiding pancreatic beta cells to target electrodes in a whole-cell biosensor for diabetes. Lab Chip 15:3880–3890CrossRefPubMed

60.

Yi L, Wang X, Dhumpa R, Schrell AM, Mukhitov N, Roper MG (2015) Integrated perfusion and separation systems for entrainment of insulin secretion from islets of Langerhans. Lab Chip 15:823–832CrossRefPubMedPubMedCentral

61.

Liu H, Yang H, Zhu D et al (2014) Systematically labeling developmental stage-specific genes for the study of pancreatic β-cell differentiation from human embryonic stem cells. Cell Res 24:1181–1200CrossRefPubMedPubMedCentral

62.

Konorov SO, Schulze HG, Gage BK et al (2015) Process analytical utility of Raman microspectroscopy in the directed differentiation of human pancreatic insulin-positive cells. Anal Chem 87:10762–10769CrossRefPubMed

63.

Ye L, Robertson MA, Mastracci TL, Anderson RM (2016) An insulin signaling feedback loop regulates pancreas progenitor cell differentiation during islet development and regeneration. Dev Biol 409:354–369CrossRefPubMed

64.

Duvillie B, Currie C, Chrones T et al (2002) Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to β-cell hyperplasia in mutant mice lacking insulin. Endocrinology 143:1530–1537PubMed

65.

Vendrame F, Pileggi A, Laughlin E et al (2010) Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T cells. Diabetes 59:947–957CrossRefPubMedPubMedCentral

66.

Hoesli CA, Raghuram K, Kiang RL et al (2011) Pancreatic cell immobilization in alginate beads produced by emulsion and internal gelation. Biotechnol Bioeng 108:424–434CrossRefPubMed

67.

Szabat M, Page MM, Panzhinskiy E et al (2016) Reduced insulin production relieves endoplasmic reticulum stress and induces β cell proliferation. Cell Metab 23:179–193CrossRefPubMed

68.

Nakayama M, Abiru N, Moriyama H et al (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220–223CrossRefPubMedPubMedCentral

69.

Bruin JE, Saber N, Braun N et al (2015) Treating diet-induced diabetes and obesity with human embryonic stem cell-derived pancreatic progenitor cells and antidiabetic drugs. Stem Cell Rep 4:605–620CrossRef

70.

ACCORD Study Group (2016) Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes. Diabetes Care 39:701–708CrossRef

71.

Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J (2008) Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31(Suppl 2):S262–S268CrossRefPubMed

72.

Johnson JD, Ao Z, Ao P et al (2009) Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transplant 18:833–845CrossRefPubMed

Title: The quest to make fully functional human pancreatic beta cells from embryonic stem cells: climbing a mountain in the clouds
Author: James D. Johnson
Publication date: 01-10-2016
Publisher: Springer Berlin Heidelberg
Published in: Diabetologia / Issue 10/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-016-4059-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The quest to make fully functional human pancreatic beta cells from embryonic stem cells: climbing a mountain in the clouds

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2016

A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children

The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets

Risk of death following admission to a UK hospital with diabetic ketoacidosis

Placental endoplasmic reticulum stress and acidosis: relevant aspects in gestational diabetes

Survival or death: a dual role for autophagy in stress-induced pericyte loss in diabetic retinopathy

LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page